Fenofibrate Monotherapy Induced Rhabdomyolysis
نویسندگان
چکیده
منابع مشابه
Fenofibrate monotherapy-induced rhabdomyolysis in a patient with type-2 diabetes.
India: The tip of the iceberg ? Indian J Med Res 1996;103:62-5. 2. Cheng AC, Currie BJ. Melioidosis: Epidemiology, pathophysiology and management. Clin Microbio Rev 2005;18:383-416. 3. Chierakul W, Wuthiekanun V, Chaowagal W, Amornchai P, Cheng AC, White NJ, et al. Short report: Disease severity and outcome of melioidosis in HIV coinfected individuals. Am J Trop Med Hyg 2005;73:1165-6. 4. Chier...
متن کاملOBSERVATIONS Simvastatin, Fenofibrate, and Rhabdomyolysis
The National Cholesterol Education Program (NCEP) guidelines recommend use of statin-fibrate combinations to treat combined dyslipidemia. Myopathy and rhabdomyolysis are reported side effects, especially with gemfibrozil-statin combinations (1). This risk is recognized to result from both pharmacodynamic and pharmacokinetic interactions. In vitro studies in human hepatocytes have shown that unl...
متن کاملRhabdomyolysis Associated with Fenofibrate Monotherapy in a Patient with Chronic Myelogenous Leukemia
Rhabdomyolysis associated with fenofibrate monotherapy is extremely rare. Here, we report a rare case of rhabdomyolysis of the psoas muscle in an 82-year-old man with chronic myelogenous leukemia (CML). He was prescribed fenofibrate because of a hypertriglyceridemia. The patient reported generalized muscle pain and right abdominal pain while receiving fenofibrate monotherapy. An abdominal compu...
متن کاملAcute renal failure due to fenofibrate monotherapy.
Rhabdomyolysis is a clinical and biochemical syndrome resulting from skeletal muscle injury and the release muscular cell constituents into extracellular fluid and the circulation (1). Rhabdomyolysis occurs due to drugs, toxins, ischemia and infections. Drug induced rhabdomyolysis mostly occurs with statins but rarely with fibrates. Fibrates are widely used for the treatment of hypertriglycerid...
متن کاملRhabdomyolysis-Induced Acute Renal Failure Following Fenofibrate Therapy: A Case Report and Literature Review
Fenofibrate, a fibric acid derivative, is used to treat diabetic dyslipidemia, hypertriglyceridemia, and combined hyperlipidemia, administered alone or in combination with statins. Rhabdomyolysis is defined as a pathological condition involving skeletal muscle cell damage leading to the release of toxic intracellular material into circulation. Its major causes include muscle compression or over...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Diabetes Care
سال: 2003
ISSN: 0149-5992,1935-5548
DOI: 10.2337/diacare.26.8.2482